Target Audience:
This program was developed for the education of family physicians and other healthcare professionals.
Accreditation & Credit Designation Statements:
This Live activity, Diabetes Therapies and Cardiovascular Risk Reduction: Taking a Closer Look at SGLT2 Inhibitors
and GLP-1 Receptor Agonists, with a beginning date of 10/09/2018, has been reviewed and is acceptable for up to 1.50
Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of
their participation in the activity.
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 CreditsTM through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.
Educational Grant:
Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals LP.
|